Skip to main content
logo
Valion Bio, Inc. (VBIO)
NASDAQ: VBIO · Real-Time Price · USD
0.2854
+0.0105 (3.82%)
At close: Aug 7, 2026, 4:00 PM EDT
0.2770
-0.0084 (-2.94%)
After-hours: Aug 7, 2026, 7:45 PM EDT

Valion Bio Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.23--1.181.841.26
Revenue Growth
-12.78%---36.09%46.38%46.16%
Cost of Revenue
0.32--0.891.541.3
Gross Profit
-0.09--0.290.3-0.04
Selling, General & Admin
2.814.773.166.888.674.72
Research & Development
4.653.131.311.661.730.88
Total Operating Expenses
7.467.94.488.5310.45.6
Operating Income
-12.03-7.9-4.48-8.25-10.1-5.63
Interest Income
0.040.020.0100-
Interest Expense
--0.15----1.82
Other Non-Operating Income (Expense)
-0.120.03----1.04
Total Non-Operating Income (Expense)
-0.69-0.10.0100-2.86
Pretax Income
-12.72-7.99-4.47-8.24-10.1-8.49
Net Income
-12.72-7.99-4.47-8.24-10.1-8.49
Earnings From Discontinued Operations
--0.89-1.19---
Net Income to Common
-13.58-8.88-5.66-8.24-10.1-8.49
Net Income Growth
------
Shares Outstanding (Basic)
2100--
Shares Outstanding (Diluted)
2100--
Shares Change
324.33%302.11%516.01%---
EPS (Basic)
-7.74-7.84-19.68-176.80--
EPS (Diluted)
-7.74-7.84-19.68-176.80--
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-11.17-7.04-5.73-8.63-8.93-5.61
Free Cash Flow Growth
------
Free Cash Flow Per Share
-6.45-6.09-19.92-184.97--
Gross Margin
-39.22%--24.40%16.25%-3.02%
Operating Margin
-5183.62%---701.11%-548.80%-448.13%
Profit Margin
-5481.03%---701.02%-548.70%-675.74%
FCF Margin
-4812.93%---733.76%-485.33%-446.46%
EBITDA
-12.02-7.89-4.47-8.24-10.09-5.63
EBITDA Margin
-5180.17%---700.42%-548.26%-447.49%
EBIT
-12.03-7.9-4.48-8.25-10.1-5.63
EBIT Margin
-5183.62%---701.11%-548.80%-448.13%
SEC Filings: 10-K · 10-Q